{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:55:21Z","timestamp":1765382121756,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00246-018-1853-4","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T02:41:48Z","timestamp":1520563308000},"page":"1016-1022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2071-0758","authenticated-orcid":false,"given":"Shinya","family":"Iwasawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Uyeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Inage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hamamichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiro","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"1853_CR1","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.jacc.2011.08.025","volume":"58","author":"D Linde Von der","year":"2011","unstructured":"Von der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Tallenberg JJ, Roos-Hesselink JW (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58:2241\u20132247. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2011.08.025","journal-title":"J Am Coll Cardiol"},{"key":"1853_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.627224","volume":"115","author":"AJ Marelli","year":"2007","unstructured":"Marelli AJ, Mackie AS, Inescu-Ittu R, Rahme E, Pilote L (2007) Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 115:163\u2013172. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.627224","journal-title":"Circulation"},{"key":"1853_CR3","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1161\/CIRCULATIONAHA.112.104786","volume":"126","author":"Z Koyak","year":"2012","unstructured":"Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ, Budts W, Zwinderman AH, Van Gelder IC, Mulder BJ (2012) Sudden cardiac death in adult congenital heart disease. Circulation 126:1944\u20131954. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.104786","journal-title":"Circulation"},{"key":"1853_CR4","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/eurheartj\/ehi396","volume":"26","author":"P Engelfriet","year":"2005","unstructured":"Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thil\u00e9n U, Kaemmerer H, Moons P, Meijboom F, Popelov\u00e1 J, Laforest V, Hirsch R, Daliento L, Thaulow E, Mulder B (2005) The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 years follow-up period: The Euro Heart Survey on adult congenital heart disease. Eur Heart J 26:2325\u20132333. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehi396","journal-title":"Eur Heart J"},{"key":"1853_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.amjcard.2011.04.021","volume":"108","author":"SC Yap","year":"2011","unstructured":"Yap SC, Harris L, Chauhan VS, Oechslin EN, Silversides CK (2011) Identifying high risk in adults with congenital heart disease and atrial arrhythmias. Am J Cardiol 108:723\u2013728. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2011.04.021","journal-title":"Am J Cardiol"},{"key":"1853_CR6","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/0002-8703(80)90214-8","volume":"100","author":"P Coumel","year":"1980","unstructured":"Coumel P, Fidelle J (1980) Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J 100:1063\u20131069","journal-title":"Am Heart J"},{"key":"1853_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0735-1097(84)80402-7","volume":"4","author":"A Garson","year":"1984","unstructured":"Garson A, Gillette PC, McVey P, Hesslein PS, Porter CBJ, Angell LK, Kaldis LC, Hittner HM (1984) Amiodarone treatment of critical arrhythmias in children and young adults. J Am Coll Cardiol 4:749\u2013755","journal-title":"J Am Coll Cardiol"},{"key":"1853_CR8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","volume":"30","author":"VR Vorperian","year":"1997","unstructured":"Vorperian VR, Havighurst TC, Miller S, January CT (1997) Adverse effects of low dose amiodarone: a meta-analysis. J Am Coll Cardiol 30:791\u2013798","journal-title":"J Am Coll Cardiol"},{"key":"1853_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1540-8159.1998.tb01068.x","volume":"21","author":"M Jafari-Fesharaki","year":"1998","unstructured":"Jafari-Fesharaki M, Scheinmann MM (1998) Adverse effects of amiodarone. Pacing Clin Electrophysiol 21:108\u2013120","journal-title":"Pacing Clin Electrophysiol"},{"key":"1853_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJM198702193160807","volume":"316","author":"JW Mason","year":"1987","unstructured":"Mason JW (1987) Amiodarone. N Engl J Med 316:455\u2013466","journal-title":"N Engl J Med"},{"key":"1853_CR11","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/0002-8703(85)90238-8","volume":"109","author":"EA Raeder","year":"1985","unstructured":"Raeder EA, Podrid PJ, Lown B (1985) Side effects and complications of amiodarone therapy. Am Heart J 109:975\u2013983","journal-title":"Am Heart J"},{"key":"1853_CR12","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(97)05281-1","volume":"350","author":"Amiodarone Trials Meta-Analysis Investigators","year":"1997","unstructured":"Amiodarone Trials Meta-Analysis Investigators (1997) Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomized trials. Lancet 350:1417\u20131424","journal-title":"Lancet"},{"key":"1853_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.1840090504","volume":"9","author":"JH Lewis","year":"1989","unstructured":"Lewis JH, Ranard RC, Caruso A, Jackson LK, Mullick F, Ishak KG, Seeff LB, Zimmerman HJ (1989) Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 9:679\u2013685","journal-title":"Hepatology"},{"key":"1853_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1177\/106002809502900605","volume":"29","author":"M Richer","year":"1995","unstructured":"Richer M, Robert S (1995) Fatal hepatotoxicity following oral administration of amiodarone. Ann Pharmacother 29:582\u2013586","journal-title":"Ann Pharmacother"},{"key":"1853_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/01.CIR.100.2.149","volume":"100","author":"SA Thorne","year":"1999","unstructured":"Thorne SA, Barnes I, Cullinan P, Somerville J (1999) Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation 100:149\u2013154","journal-title":"Circulation"},{"key":"1853_CR16","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/0735-1097(90)90251-J","volume":"15","author":"P Guccione","year":"1990","unstructured":"Guccione P, Paul T, Garson A (1990) Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, and moderate side effects. J Am Coll Cardiol 15:1118\u20131124","journal-title":"J Am Coll Cardiol"},{"key":"1853_CR17","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1253\/circj.CJ-15-0042","volume":"79","author":"D Takeuchi","year":"2015","unstructured":"Takeuchi D, Honda K, Shinohara T, Inai K, Toyohara K, Nakanishi T (2015) Incidence, clinical course, and risk factors of amiodarone-induced thyroid dysfunction in Japanese adults with congenital heart disease. Circ J 79:1828\u20131834. \n                    https:\/\/doi.org\/10.1253\/circj.CJ-15-0042","journal-title":"Circ J"},{"key":"1853_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/01.CIR.88.2.764","volume":"88","author":"K Nademanee","year":"1993","unstructured":"Nademanee K, Singh BN, Stevenson WG, Weiss JN (1993) Amiodarone and post-MI patients. Circulation 88:764\u2013768","journal-title":"Circulation"},{"key":"1853_CR19","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1093\/eurheartj\/ehq249","volume":"31","author":"H Baumgartner","year":"2010","unstructured":"Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, Gatzoulis MA, Gohlke-Baerwolf C, Kaemmerer H, Kilner P, Meijboom F, Mulder BJ, Oechslin E, Oliver JM, Serraf A, Szatmari A, Thaulow E, Vouhe PR, Walma E, Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC), Association for European Pediatric Cardiology (AEPC), ESC Committee for Practice Guidelines (CPG) (2010) ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 31:2915\u20132957. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehq249","journal-title":"Eur Heart J"},{"key":"1853_CR20","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1253\/circj.71.1610","volume":"71","author":"Y Yamada","year":"2007","unstructured":"Yamada Y, Shiga T, Matsuda N, Hagiwara N, Kasanuki H (2007) Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone. Circ J 71:1610\u20131616","journal-title":"Circ J"},{"key":"1853_CR21","doi-asserted-by":"publisher","first-page":"CD005049","DOI":"10.1002\/14651858.CD005049.pub4","volume":"3","author":"C Lafuente-Lafuente","year":"2015","unstructured":"Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J (2015) Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 3:CD005049. \n                    https:\/\/doi.org\/10.1002\/14651858.CD005049.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"1853_CR22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJM200003303421302","volume":"342","author":"D Roy","year":"2000","unstructured":"Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagn\u00e9 P, Nattel S, Thibault B (2000) Amiodarone to prevent recurrence of atrial fibrillation: Canadian trial of atrial fibrillation investigators. N Engl J Med 342:913\u2013920. \n                    https:\/\/doi.org\/10.1056\/NEJM200003303421302","journal-title":"N Engl J Med"},{"key":"1853_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0002-9149(99)80799-1","volume":"76","author":"SH Chun","year":"1995","unstructured":"Chun SH, Sager PT, Stevenson WG, Nademanee K, Middlekauff HR, Singh BN (1995) Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 76:47\u201350","journal-title":"Am J Cardiol"},{"key":"1853_CR24","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1001\/jama.1992.03480240051033","volume":"267","author":"AT Gosselink","year":"1992","unstructured":"Gosselink AT, Crijns HJ, Van Gelder IC, Hillige H, Wiesfeld AC, Lie KI (1992) Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 267:3289\u20133293","journal-title":"JAMA"},{"key":"1853_CR25","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.amjcard.2013.07.029","volume":"112","author":"Z Koyak","year":"2013","unstructured":"Koyak Z, Kroon B, de Groot JR, Wagenaar LJ, van Dijk AP, Mulder BA, Van Gelder IC, Post MC, Mulder BJ, Bouma BJ (2013) Efficacy of anti-arrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias. Am J Cardiol 112:1461\u20131467. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2013.07.029","journal-title":"Am J Cardiol"},{"key":"1853_CR26","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1253\/circj.66.600","volume":"66","author":"T Shiga","year":"2002","unstructured":"Shiga T, Wakaumi M, Imai T, Suzuki T, Hosaka F, Yamada Y, Matsuda N, Shoda M, Sugiura R, Hagiwara N, Kasanuki H (2002) Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure. Circ J 66:600\u2013604","journal-title":"Circ J"},{"key":"1853_CR27","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0735-1097(99)00327-7","volume":"34","author":"MJ Domanski","year":"1999","unstructured":"Domanski MJ, Sakseena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E (1999) Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias: AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 34:1090\u20131095","journal-title":"J Am Coll Cardiol"},{"key":"1853_CR28","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1253\/jcj.65.958","volume":"65","author":"T Shiga","year":"2001","unstructured":"Shiga T, Wakaumi M, Matsuda N, Shoda M, Hagiwara N, Sato K, Kasanuki H (2001) Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. Jpn Circ J 65:958\u2013960","journal-title":"Jpn Circ J"},{"key":"1853_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/01.CIR.82.1.51","volume":"82","author":"RE Dusman","year":"1990","unstructured":"Dusman RE, Stanton MS, Miles WM, Klein LS, Zipes DP, Fineberg NS, Heger JJ (1990) Clinical features of amiodarone-induced pulmonary toxicity. Circulation 82:51\u201359","journal-title":"Circulation"},{"key":"1853_CR30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1378\/chest.86.4.541","volume":"86","author":"PJ Kudenchuk","year":"1984","unstructured":"Kudenchuk PJ, Pierson DJ, Greene HL, Graham EL, Sears GK, Trobaugh GB (1984) Prospective evaluation of amiodarone pulmonary toxicity. Chest 86:541\u2013548","journal-title":"Chest"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-018-1853-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1853-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T19:14:51Z","timestamp":1552072491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-018-1853-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1853"],"URL":"https:\/\/doi.org\/10.1007\/s00246-018-1853-4","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"type":"print","value":"0172-0643"},{"type":"electronic","value":"1432-1971"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"7 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None of the authors have conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}